Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Castagna

Showing results (141-150 of 467) with videos related to

Pageof 47
Sort By:
Le Infezioni in Medicina|December 1, 2020
Beyond Italian guidelines in the management of HIV-positive patientMassimo Andreoni, Andrea Antinori, Antonella Castagna, et al.
Frontiers in Medicine|October 4, 2023
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemicRebecka Papaioannu Borjesson, Laura Galli, Camilla Muccini, et al.
Antiviral Therapy|April 29, 2022
Rilpivirine plus cobicistat-boosted darunavir as alternative to standard three-drug therapy in HIV-infected, virologically suppressed subjects: Final results of the PROBE 2 trialFranco Maggiolo, Nicola Gianotti, Laura Comi, et al.
Journal of Clinical Immunology|April 8, 2006
Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patientsSamuele E Burastero, Clara Paolucci, Daniela Breda, et al.
Physiologia Plantarum|June 19, 2021
Secondary metabolites and related genes in Vitis vinifera L. cv. Tempranillo grapes as influenced by ultraviolet radiation and berry developmentMaría-Ángeles Del-Castillo-Alonso, Laura Monforte, Rafael Tomás-Las-Heras, et al.
The New Microbiologica|May 29, 2023
No need to modify treatment within the first month after rapid start of a tailored antiretroviral therapy: the TWODAY StudyNicola Gianotti, Laura Galli, Michela Sampaolo, et al.
Journal of Medical Virology|August 26, 2025
Hepatitis B Viral Rebound in People With HIV Under HBV-Active Antiretroviral TherapyCostanza Bertoni, Sara Diotallevi, Riccardo Lolatto, et al.
The Journal of Infectious Diseases|January 6, 2026
A humoral dilemma: reassessing monkeypox virus neutralizing antibodies at more than two years from Mpox or MVA-BN vaccinationNicolò Moschetta, Elena Criscuolo, Angelo Roberto Raccagni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 23, 2023
Viral Hepatitis and Human Papillomavirus Vaccination During HIV Pre-Exposure Prophylaxis: Factors Associated With Missed VaccinationAngelo Roberto Raccagni, Daniele Ceccarelli, Benedetta Trentacapilli, et al.
IJID Regions|August 27, 2024
Tick-borne encephalitis seroprevalence in northern Italy: a cross-sectional study on a randomly selected populationAntonella Castagna, Stefania Schiavon, Giulio Mengozzi, et al.
Pageof 47

Showing results (141-150 of 467) with videos related to

Sort By:
Pageof 47
Le Infezioni in Medicina|December 1, 2020
Beyond Italian guidelines in the management of HIV-positive patientMassimo Andreoni, Andrea Antinori, Antonella Castagna, et al.
Frontiers in Medicine|October 4, 2023
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemicRebecka Papaioannu Borjesson, Laura Galli, Camilla Muccini, et al.
Antiviral Therapy|April 29, 2022
Rilpivirine plus cobicistat-boosted darunavir as alternative to standard three-drug therapy in HIV-infected, virologically suppressed subjects: Final results of the PROBE 2 trialFranco Maggiolo, Nicola Gianotti, Laura Comi, et al.
Journal of Clinical Immunology|April 8, 2006
Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patientsSamuele E Burastero, Clara Paolucci, Daniela Breda, et al.
Physiologia Plantarum|June 19, 2021
Secondary metabolites and related genes in Vitis vinifera L. cv. Tempranillo grapes as influenced by ultraviolet radiation and berry developmentMaría-Ángeles Del-Castillo-Alonso, Laura Monforte, Rafael Tomás-Las-Heras, et al.
The New Microbiologica|May 29, 2023
No need to modify treatment within the first month after rapid start of a tailored antiretroviral therapy: the TWODAY StudyNicola Gianotti, Laura Galli, Michela Sampaolo, et al.
Journal of Medical Virology|August 26, 2025
Hepatitis B Viral Rebound in People With HIV Under HBV-Active Antiretroviral TherapyCostanza Bertoni, Sara Diotallevi, Riccardo Lolatto, et al.
The Journal of Infectious Diseases|January 6, 2026
A humoral dilemma: reassessing monkeypox virus neutralizing antibodies at more than two years from Mpox or MVA-BN vaccinationNicolò Moschetta, Elena Criscuolo, Angelo Roberto Raccagni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 23, 2023
Viral Hepatitis and Human Papillomavirus Vaccination During HIV Pre-Exposure Prophylaxis: Factors Associated With Missed VaccinationAngelo Roberto Raccagni, Daniele Ceccarelli, Benedetta Trentacapilli, et al.
IJID Regions|August 27, 2024
Tick-borne encephalitis seroprevalence in northern Italy: a cross-sectional study on a randomly selected populationAntonella Castagna, Stefania Schiavon, Giulio Mengozzi, et al.
Pageof 47